http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2073737-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d709e3167fa2f99a1803c9cfeb0aca63 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-08 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-08 |
| filingDate | 1981-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1981-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | GB-2073737-A |
| titleOfInvention | Rifamycins |
| abstract | New rifamycin compounds of the formulae I and II <IMAGE> Y=H or CH3CO; R1 is C1-C7 alkyl or C3-C4 alkenyl, R2 is C1-C7 alkyl, C2-C4 chloroalkyl, C3-C4 alkenyl, Cycloalkyl having 3 to 7 C atoms in the ring, cycloalkyl alkyl having 3 to 6 C atoms in the ring, phenyl, bornyl, or C7-C8 aralkyl, unsubstituted or mono-substituted by a halogen atom in the aryl group; or NR1R2 is a cyclic moiety having 5 to 8 C atoms unsubstituted or substituted by 1 or 2 CH3 group(s), 4-alkyl-1-piperzinyl, morpholino or 1,2,3,4- tetrahydroisoquinolinyl, which inhibit the growth of gram positive bacteria and mycobacterium tuberculosis, are prepared by formation of the imino group. |
| priorityDate | 1980-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 60.